Data as of Q4 2025 (Dec 31, 2025)

Tetragon Partners GP Ltd

•CIK: 1515070•Filing: Q4 2025

**Tetragon Partners GP Ltd** manages $474M across a concentrated portfolio of 28 positions. The fund exhibits significant conviction in its top holdings, led by a substantial allocation to PATH at $286.0M. Further notable positions include KGEI ($27.3M) and LYFT ($19.4M), suggesting a focused, high-conviction approach across its investment universe.

Total AUM
$474.3M
QoQ Performance
+14.6%
Positions
28
Top 10 Concentration
86.8%
Latest Filing
Q4 2025

Top Holdings Allocation

PATH
KGEI
PATH60.3%
KGEI5.7%
LYFT4.1%
AUTL4.0%
CXM3.6%
WK2.7%
ANNX2.2%
PRAX1.4%

📈 Biggest Buys

PATH
UIPATH INC
+2.9%
60.3% of portfolio
PRAX
PRAXIS PRECISION MEDICINES I
NEW
1.4% of portfolio
RAPT
RAPT THERAPEUTICS INC
NEW
0.9% of portfolio
AGIO
AGIOS PHARMACEUTICALS INC
NEW
0.9% of portfolio
HRMY
HARMONY BIOSCIENCES HLDGS IN
NEW
0.7% of portfolio

📉 Biggest Sells

AXSM
AXSOME THERAPEUTICS INC
-42.0%
1.0% of portfolio
TCE2
CELLDEX THERAPEUTICS INC NEW
-19.7%
1.4% of portfolio
MBX
MBX BIOSCIENCES INC
-19.4%
1.0% of portfolio
IMVT
IMMUNOVANT INC
-11.8%
0.9% of portfolio
KGEI
KOLIBRI GLOBAL ENERGY INC
-1.9%
5.7% of portfolio

Sector Breakdown

Other100.0%

🚪 Exited Positionssold since Q3 2025

TARS
TARSUS PHARMACEUTICALS INC
SOLD
$7.4M
HYG
ISHARES TR
SOLD
$5.9M
SRRK
SCHOLAR ROCK HLDG CORP
SOLD
$4.4M
TECX
TECTONIC THERAPEUTIC INC
SOLD
$3.8M
ABVX
ABIVAX SA
SOLD
$2.5M
+12 more exited positions

Changes from Q3 2025

NEW9 new positions
↑7 increased
↓6 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

📌 Top Holdings

PATH60.3%
UIPATH INC
$286.0M
KGEI5.7%
KOLIBRI GLOBAL ENERGY INC
$27.3M
LYFT4.1%
LYFT INC
$19.4M
AUTL4.0%
AUTOLUS THERAPEUTICS PLC
$18.9M
CXM3.6%
SPRINKLR INC
$17.1M

⚖️ Compare Fund

Compare this fund's holdings with other hedge funds.

🎯 Fund Movement Signals

See AI-analyzed fund movement signals and accumulation patterns.

👤 Insider Trading

See what corporate insiders are buying and selling.